A protein-binding product, a device containing said protein-binding product and a method for extracorporeal reduction of the level of protein in blood plasma
AssigneeGlycorex Transplantation AB
InventorKurt NILSSON
Life of this patent
Estimating the term…
Abstract
A protein-binding product comprising one or more porous polymer beads, wherein at least one ligand is bound to the surfaces of said polymer beads via a spacer (R), and wherein said at least one ligand is Galβ1-3HexNAcβ—O—, Galβ1-4GlcNAcβ—O— and/or a derivative thereof, is disclosed as well as a device containing said protein-binding product and a method for reduction of the level of at least one galactose-binding protein and optionally at least one other protein in human blood plasma.
Claims18
A protein-binding product comprising one or more porous polymer beads, wherein at least one ligand is bound to the surfaces of said polymer beads via a spacer (R), and wherein said at least one ligand is Galβ1-3HexNAcβ—O—, Galβ1-4GlcNAcβ—O— and/or a derivative thereof.
The protein-binding product according to any one of the preceding claims, wherein said at least one ligand has the ability to bind to at least one galactose-binding protein, preferably a galectin, and optionally has the ability to bind at least one other protein, preferably an antibody, more preferably a blood group A specific antibody, a blood group B specific antibody, or an autoantibody.
A protein-binding product with the ability to bind galectin and with the ability to bind an autoantibody, preferably AChR (acetylcholine receptor) antibody or a MuSK (muscle-specific kinase) receptor antibody, or a toxin in human blood plasma.
The protein-binding product according to any one of the preceding claims, wherein said at least one ligand has the ability to specifically bind to galectins in human blood plasma, preferably galectin-1, galectin-3, and galectin-8.
The protein-binding product according to any one of the preceding claims, wherein the concentration of the ligand is in a range of 0.1-20 μmol per mL polymer, preferably 5-20 μmol per mL polymer.
The protein-binding product according to any one of the preceding claims, wherein the concentration of the derivative of at least one of Galβ1-3HexNAcβ—O— or Galβ1-4GlcNAcβ—O— is in a range of 0.1-5 μmol per mL polymer.
The protein-binding product according to any one of the preceding claims, wherein the spacer (R) is covalently bound to the surfaces of said porous polymer beads and is glycosidically bound to the ligand.
The protein-binding product according to any one of the preceding claims, wherein the spacer is chosen from the group consisting of (CH2)nNH—, (CH2)nPhNH—, PhNH— and Ph(CH2)nNH—, wherein Ph is a phenyl group and n is an integer, preferably wherein n is one of 1, 2, 3, 4, 5 or 6.
The protein-binding product according to any one of the preceding claims, wherein said porous polymer beads are agarose or cross-linked agarose beads, hydroxymethacrylate beads or other porous plastic beads.
Dependencies are inferred from the claim text.